Be aware that there seems to be a coordinated effort to not allow the TRUTH to be known and understood surrounding Nano.
For example, Monday's incredible PR, datelined from Shelton, CT (a formal Company PR, in other words), was essentially IMMEDIATELY DELETED. (See the Access Wire of 3-16-2020 in CHINESE ONLY cited below.)
Very few potential investors realize that Nano has "NOW COMPLETED THE NEXT TWO MILESTONES, NAMELY SYNTHESIS OF THE TEST CANDIDATES, AND DEVELOPMENT OF ANTI-CoV ASSAYS FOR TESTING THEM." (The last sentence of that PR).
Secondly, because of the urgency involved with finding a cure for Coronavirus, the FDA may relax the many "hoops" that have heretofore been necessary before entering HUMAN trials, a HUGE PLUS when read in conjunction with Nano actually having completed synthesis of such a drug.
BOTTOM LINE:
IN MY 57 YEAR CAREER OF FINDING "SPECIAL SITUATION" COMPANIES, I HAVE NEVER SEEN A MORE UNDERVALUED OPPORTUNITY.
BUY----BUY----BUY, as Cramer would say, if you consider adding to your Nano shares.
THE "SET-UP", AS CHARTISTS WOULD SAY, IS PERFECT!
D
White House sought to exand virus drug tests over objections from FDA, WSJ saysThe White House considered issuing an executive order to significantly expand the use of investigational drugs against the new coronavirus, but the FDA's senior scientists warned it could pose unneeded risks to patients, The Wall Street Journal's Thomas M. Burton reports, citing a senior government official. President Trump tweeted that he is planning a briefing Wednesday that will pertain to the FDA, but it is unclear if that briefing would deal with expanded use of testing drugs against the virus. Small-to-mid cap publicly traded companies working on coronavirus treatment and testing include Inovio (INO), Co-Diagnostics (CODX), iBio (IBIO) and NanoViricides (NNVC). Reference Link INO CODX IBIO NNVC
Read more at:
thefly.com
( I have been told this is Hebrew)
NanoViricides, Inc.
ACCESSWIRE•March 16, 2020
finance.yahoo.com
|
